How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

11,625 results for

Intrauterine Device

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

101. Study on Medical Records of Women Using a Coil (Intrauterine Device = IUD) for Birth Control to Analyze the Risk That a Coil Will Slip Out or Perforate the Womb in Relation to Breastfeeding, to the Point in Time When the Coil Was Inserted After Childbirth

Study on Medical Records of Women Using a Coil (Intrauterine Device = IUD) for Birth Control to Analyze the Risk That a Coil Will Slip Out or Perforate the Womb in Relation to Breastfeeding, to the Point in Time When the Coil Was Inserted After Childbirth Study on Medical Records of Women Using a Coil (Intrauterine Device = IUD) for Birth Control to Analyze the Risk That a Coil Will Slip Out or Perforate the Womb in Relation to Breastfeeding, to the Point in Time When the Coil Was Inserted (...) After Childbirth and in Relation to Different Types of Coils. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Study on Medical Records of Women Using a Coil (Intrauterine Device = IUD) for Birth Control

2018 Clinical Trials

102. Effect of a novel copper-containing intrauterine device material on the endometrial environment in rabbits. (Abstract)

Effect of a novel copper-containing intrauterine device material on the endometrial environment in rabbits. This study aimed to determine whether intrauterine placement of a novel composite material [copper (Cu) microparticles, low-density polyethylene, and methyl vinyl silicone rubber (Cu/LDPE/MVQ)] could prevent pregnancy in rabbits, and to evaluate the effects of Cu/LDPE/MVQ on the endometrial environment.Eighty sexually mature female rabbits were randomly divided into four groups (n=20 each (...) Cu-containing intrauterine device material exhibits a similar effect in prevention of pregnancy with bare copper, and lower levels of inflammatory markers.This study demonstrates the potential of the novel Cu/LDPE/MVQ microcomposite material as a future substitute for conventional intrauterine device materials.Copyright © 2018 Elsevier Inc. All rights reserved.

2018 Contraception

103. Impact of the levonorgestrel-releasing intrauterine device on controlled ovarian stimulation outcomes. (Abstract)

Impact of the levonorgestrel-releasing intrauterine device on controlled ovarian stimulation outcomes. To report differences in ovarian stimulation outcomes in women using a levonorgestrel-releasing intrauterine device (LNG-IUD).Retrospective cohort study.University-based infertility practice.Female patients pursuing either social oocyte cryopreservation or oocyte donation.Chart review of all female patients presenting from January 1, 2012, to June 30, 2017, for social oocyte cryopreservation

2018 Fertility and Sterility

104. Intraoperative ultrasound assistance for the surgical removal of lost intrauterine device. (Abstract)

Intraoperative ultrasound assistance for the surgical removal of lost intrauterine device. A 45-year woman, carrying an IUD for 2 years, was referred to our emergency unit for pelvic pain and bleeding. At vaginal examination, the strings of the IUD were not identified. Laboratory parameters were unremarkable. The abdominal radiography documented the presence of IUD in the abdominal cavity (FIG.1). During laparoscopy, the surgeon was unable to localize the IUD and an intraoperative ultrasound

2018 Ultrasound in Obstetrics and Gynecology

105. Six-month expulsion of postplacental copper intrauterine devices placed after vaginal delivery. Full Text available with Trip Pro

Six-month expulsion of postplacental copper intrauterine devices placed after vaginal delivery. Immediate placement of an intrauterine device after vaginal delivery is safe and convenient, but longitudinal data describing clinical outcomes have been limited.We sought to determine the proportion of TCu380A (copper) intrauterine devices expelled, partially expelled, malpositioned, and retained, as well as contraceptive use by 6 months postpartum, and determine risk factors for expulsion (...) and partial expulsion.In this prospective, observational study, women who received a postplacental TCu380A intrauterine device at vaginal delivery were enrolled postpartum. Participants returned for clinical follow-up at 6 weeks, and for a research visit with a pelvic exam and ultrasound at 6 months. We recorded intrauterine device outcomes and 6-month contraceptive use. Partial expulsion was defined as an intrauterine device protruding from the external cervical os, or a transvaginal ultrasound showing

2018 American Journal of Obstetrics and Gynecology

106. The intrauterine device as emergency contraception: How much do young women know? Full Text available with Trip Pro

The intrauterine device as emergency contraception: How much do young women know? Unprotected intercourse is common, especially among teens and young women. Access to intrauterine device (IUD) as emergency contraception (EC) can help interested patients more effectively prevent unintended pregnancy and can also offer ongoing contraception. This study evaluated young women's awareness of IUD as EC and interest in case of need.We conducted a secondary analysis of data from young women aged 18

2018 Contraception Controlled trial quality: uncertain

107. Ultrasound-guided intrauterine device insertion: a step closer to painless insertion: a randomized control trial. (Abstract)

Ultrasound-guided intrauterine device insertion: a step closer to painless insertion: a randomized control trial. To reduce the pain and duration of the intrauterine device (IUD) insertion procedure through minimizing instrumentation and using trans-abdominal sonography (TAS).This randomized control trial was conducted in a university hospital and included 102 eligible females, fulfilling the inclusion criteria. They were randomly assigned into two groups via 1:1 computer-based randomization

2018 The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception Controlled trial quality: uncertain

108. Naproxen Sodium for Pain Control With Intrauterine Device Insertion: A Randomized Controlled Trial. (Abstract)

Naproxen Sodium for Pain Control With Intrauterine Device Insertion: A Randomized Controlled Trial. 28538475 2018 07 16 2018 12 02 1873-233X 129 6 2017 06 Obstetrics and gynecology Obstet Gynecol Naproxen Sodium for Pain Control With Intrauterine Device Insertion: A Randomized Controlled Trial. 1135-1136 10.1097/AOG.0000000000002078 Creinin Mitchell D MD University of California, Davis, California. eng Journal Article Comment United States Obstet Gynecol 0401101 0029-7844 57Y76R9ATQ Naproxen (...) AIM IM Obstet Gynecol. 2016 Dec;128(6):1306-1313 27824753 Obstet Gynecol. 2017 Jun;129(6):1136 28538476 Double-Blind Method Humans Intrauterine Devices Naproxen Pain Pain Management 2017 5 25 6 0 2017 5 26 6 0 2018 7 17 6 0 ppublish 28538475 10.1097/AOG.0000000000002078 00006250-201706000-00029

2018 Obstetrics and Gynecology Controlled trial quality: predicted high

109. Case Report: Cervicovaginal Co-Colonization with <i>Entamoeba gingivalis</i> and <i>Entamoeba polecki</i> in Association with an Intrauterine Device. Full Text available with Trip Pro

Case Report: Cervicovaginal Co-Colonization with Entamoeba gingivalis and Entamoeba polecki in Association with an Intrauterine Device. Amoebic trophozoites were identified in the cervicovaginal smear of a U.S. patient without travel history at the time of intrauterine device (IUD) removal. Subsequent morphologic analysis and DNA sequencing identified a mixed cervicovaginal colonization of the female genital tract with both Entamoeba gingivalis and Entamoeba polecki in association

2018 American Journal of Tropical Medicine & Hygiene

110. Dimensional analysis of the endometrial cavity: how many dimensions should the ideal intrauterine device or system have? Full Text available with Trip Pro

Dimensional analysis of the endometrial cavity: how many dimensions should the ideal intrauterine device or system have? The geometrical shape of the human uterus most closely approximates that of a prolate ellipsoid. The endometrial cavity itself is more likely to also have the shape of a prolate ellipsoid especially when the extension of the cervix is omitted. Using this information and known endometrial cavity volumes and lateral and vertical dimensions, it is possible to calculate (...) and breadth measurements indicate that the AP diameter may vary from 6.29 to 38.2 mm. These measurements confirm the difficulty of getting a fixed-frame intrauterine device (IUD) to accommodate to a space of highly variable dimensions. This is especially true of three-dimension IUDs. A one-dimensional frameless IUD is most likely to be able to conform to this highly variable space and shape.The endometrial cavity may assume many varied prolate ellipsoid configurations where one or more measurements may

2018 International journal of women's health

111. Studies of acute and subchronic systemic toxicity associated with a copper/low-density polyethylene nanocomposite intrauterine device Full Text available with Trip Pro

Studies of acute and subchronic systemic toxicity associated with a copper/low-density polyethylene nanocomposite intrauterine device The physiologic safety of devices and materials intended for clinical implantation should be evaluated. This study, a logical extension of our previous work, aimed to investigate the safety of a novel contraceptive device, the copper/low-density polyethylene nanocomposite intrauterine device (nano-Cu/LDPE IUD), through studies of its potential toxicity after

2018 International journal of nanomedicine

112. Small-sized ‘gold standard’ copper intrauterine devices may have lower discontinuation and fewer side effects than standard-sized counterparts

Small-sized ‘gold standard’ copper intrauterine devices may have lower discontinuation and fewer side effects than standard-sized counterparts Small-sized ‘gold standard’ copper intrauterine devices may have lower discontinuation and fewer side effects than standard-sized counterparts | BMJ Sexual & Reproductive Health blog by By Hannat Akintomide Pain and bleeding are the commonest unwanted effects of copper intrauterine contraception and pose barriers to continued use. When choosing copper (...) intrauterine contraception, the Faculty of Sexual and Reproductive Healthcare recommends a ‘gold standard’ intrauterine device (IUD). Gold standard IUDs are the most efficacious and have the longest duration of use. They contain at least 380mm 2 of copper and have banded copper on the arms. The most popular gold standard IUDs are the TT 380 Slimline® ( arm width 32 mm, stem length ≥33.6 mm) and the T-safe 380A® and T-safe 380A QL® ( 32 mm x 35.95 mm), each licensed for 10 years of use. The Mini TT 380

2019 Journal of Family Planning and Reproductive Health Care blog

113. IUB? SCu300A intrauterine device for contraception

IUB? SCu300A intrauterine device for contraception IUB™ SCu300A intrauterine device for contraception IUB™ SCu300A intrauterine device for contraception NIHR HSC Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NIHR HSC. IUB™ SCu300A intrauterine device for contraception. Birmingham: NIHR Horizon Scanning Centre (NIHR HSC). Horizon (...) Scanning Review. 2013 Final publication URL Indexing Status Subject indexing assigned by CRD MeSH Contraception; Females; Intrauterine Devices Language Published English Country of organisation England English summary An English language summary is available. Address for correspondence The NIHR Horizon Scanning Centre, Department of Public Health, Epidemiology, and Biostatistics, School of Health&Population Sciences, University of Birmingham, 90 Vincent Drive, Edgbaston, Birmingham, B15 2SP. United

2013 Health Technology Assessment (HTA) Database.

114. Prolonged Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device - Two Years Beyond FDA-Approved Duration. Full Text available with Trip Pro

Prolonged Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device - Two Years Beyond FDA-Approved Duration. The subdermal contraceptive implant and the 52-mg levonorgestrel intrauterine device are currently Food and Drug Administration approved for 3 and 5 years of use, respectively. Limited available data suggested both of these methods are effective beyond that time. Demonstration of prolonged effectiveness will improve the cost-effectiveness of the device, and potentially (...) patient continuation and satisfaction.We sought to evaluate the effectiveness of the contraceptive implant and the 52-mg hormonal intrauterine device in women using the method for 2 years beyond the current Food and Drug Administration-approved duration.We initiated this ongoing prospective cohort study in January 2012. We are enrolling women using the contraceptive implant or 52-mg levonorgestrel intrauterine device for a minimum of 3 and 5 years, respectively (started intrauterine device in ≥2007

2017 American Journal of Obstetrics and Gynecology

115. Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: A retrospective review. Full Text available with Trip Pro

Two-year continuation of intrauterine devices and contraceptive implants in a mixed-payer setting: A retrospective review. As the popularity of long-acting reversible contraception increases, so does the need for accurate data on method continuation in diverse clinical settings. We determined 2-year continuation rates for the levonorgestrel 52-mg intrauterine device, the copper T380A intrauterine device, and the 68-mg etonogestrel contraceptive implant in an academic healthcare system (...) with mixed-payer reimbursement.The purpose of this study was to examine the proportion and characteristics of women who continue intrauterine device and implant use to 2 years and to relate continuation to device type when controlling for patient characteristics.This retrospective chart review assessed University of Utah Healthcare System patients who had an intrauterine device or contraceptive implant inserted between January 1, 2004, and December 31, 2012. We identified users and dates of insertions

2017 American Journal of Obstetrics and Gynecology

116. Authors' response to 'Comment on 'Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial' '. Full Text available with Trip Pro

Authors' response to 'Comment on 'Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial' '. 29018110 2018 07 05 2045-2098 43 4 2017 Oct The journal of family planning and reproductive health care J Fam Plann Reprod Health Care Authors' response to 'Comment on 'Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic (...) ; tess@lawrie.com. eng Letter England J Fam Plann Reprod Health Care 101087687 1471-1893 human immunodeficiency virus intrauterine devices long-acting progestogens Competing interests: None declared. 2017 07 10 2017 07 11 2017 10 12 6 0 2017 10 12 6 0 2017 10 12 6 1 ppublish 29018110 jfprhc-2017-101864 10.1136/jfprhc-2017-101864

2017 The Journal of Family Planning and Reproductive Health Care Controlled trial quality: uncertain

117. Comment on 'Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial'. (Abstract)

Comment on 'Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial'. 28756404 2018 07 05 2045-2098 43 4 2017 Oct The journal of family planning and reproductive health care J Fam Plann Reprod Health Care Comment on 'Effects of injectable progestogen contraception versus the copper intrauterine device on HIV acquisition: sub-study of a pragmatic randomised controlled trial'. 342 10.1136/jfprhc (...) @stanford.edu. eng Letter 2017 07 29 England J Fam Plann Reprod Health Care 101087687 1471-1893 hormonal contraception human immunodeficiency virus intrauterine systems long-acting progestogens long-acting reversible contraception Competing interests: None declared. 2017 8 2 6 0 2017 8 2 6 1 2017 7 31 6 0 ppublish 28756404 jfprhc-2017-101827 10.1136/jfprhc-2017-101827

2017 The Journal of Family Planning and Reproductive Health Care Controlled trial quality: uncertain

118. Comments on manuscript: vaginal misoprostol prior to intrauterine device insertion in women delivered only by elective cesarean section: a randomized double-blind clinical trial. (Abstract)

Comments on manuscript: vaginal misoprostol prior to intrauterine device insertion in women delivered only by elective cesarean section: a randomized double-blind clinical trial. 28189667 2017 10 19 2018 12 02 1879-0518 95 4 2017 04 Contraception Contraception Comments on manuscript: vaginal misoprostol prior to intrauterine device insertion in women delivered only by elective cesarean section: a randomized double-blind clinical trial. 434-435 S0010-7824(17)30038-0 10.1016/j.contraception (...) . 2017 Apr;95(4):435 28188744 Administration, Intravaginal Cesarean Section Double-Blind Method Female Humans Intrauterine Devices Misoprostol Pregnancy 2017 01 20 2017 01 21 2017 2 13 6 0 2017 10 20 6 0 2017 2 13 6 0 ppublish 28189667 S0010-7824(17)30038-0 10.1016/j.contraception.2017.01.012

2017 Contraception Controlled trial quality: predicted high

119. Levonorgestrel-Releasing Intrauterine Contraceptive Device in the Peritoneal Cavity: A Report of Two Cases. (Abstract)

Levonorgestrel-Releasing Intrauterine Contraceptive Device in the Peritoneal Cavity: A Report of Two Cases. In modern gynecology an intrauterine device (IUD) with levonorgestrel is often used as a method of contraception. The levonorgestrel-releasing intrauterine system is small and T-shaped. In Slovenia, only a gynecologist may insert it. CASES: We present 2 clinical cases in which, despite strong evidence that no perforation had occurred during insertion, the IUD was found outside the uterus (...) . If the IUD threads are not visible or the IUD cannot be located in the uterine cavity, an X-ray of the abdomen must be performed. If the IUD is found in the abdominal cavity outside the uterus, removal by laparoscopy is carried out.Given the large number of inserted IUDs, the complications associated with the levonorgestrel-releasing intrauterine system are quite rare, and therefore it remains one of the most widely used contraceptive methods.

2017 Journal of Reproductive Medicine

120. Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury Full Text available with Trip Pro

Levonorgestrel-Releasing Intrauterine Device-Related Acute Liver Injury Oral contraceptives have long been associated with liver injury. However, very little attention is paid to the metabolic side effects of hormone-releasing intrauterine devices (IUDs). These devices are generally considered safe and commonly used. We report for the first time acute liver injury associated with a levonorgestrel-releasing IUD. Our patient did not have any comorbidities that could have caused or exacerbated (...) liver injury. A detailed workup and liver biopsy remained negative for any other potential cause of liver injury. The patient's symptoms resolved with removal of the device. She remained symptom free on subsequent outpatient follow-ups.

2017 Case reports in gastroenterology

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>